During immune responses, naive T cells transition from small quiescent cells to rapidly cycling cells. We have found that T cells lacking TAX1BP1 exhibit delays in growth of cell size and cell cycling. TAX1BP1-deficient T cells exited G 0 but stalled in S phase, due to both bioenergetic and biosynthetic defects. These defects were due to deficiencies in mTOR complex formation and activation. These mTOR defects in turn resulted from defective autophagy induction. TAX1BP1 binding of LC3 and GABARAP via its LC3-interacting region (LIR), but not its ubiquitin-binding domain, supported T cell proliferation. Supplementation of TAX1BP1-deficient T cells with metabolically active L-cysteine rescued mTOR activation and proliferation but not autophagy. These studies reveal that TAX1BP1 drives a specialized form of autophagy, providing critical amino acids that activate mTOR and enable the metabolic transition of activated T cells.
In Brief
Naive T cells undergo major bioenergetic and biosynthetic metabolic transitions as they initiate proliferation in response to T cell activation. Whang et al. now show that the ubiqutin binding protein TAX1BP1 is critical for autophagic flux and L-cysteine-dependent activation of mTORC in newly activated T cells.
INTRODUCTION
Productive T cell immune responses require the transition of resting T cells to rapidly cycling cells. While the initial activation of T cells triggers a number of signaling cascades, the proliferation and differentiation of these cells requires a series of metabolic transitions (Fox et al., 2005; MacIver et al., 2013; Pearce et al., 2013) . These transitions include bioenergetic events that generate ATP as well as biosynthetic events that accumulate building blocks required for protein, lipid, and nucleic acid synthesis. Although certain key steps, e.g., mTOR activation, have been described to support these transitions, the molecular processes by which activated T cells become proliferative cells are incompletely understood (Pollizzi and Powell, 2014) .
TAX1BP1 is a ubiquitin binding protein that binds the human T cell leukemia virus (HTLV)-1 Tax protein, the tumor necrosis factor receptor associate factor-6 (TRAF6), and the ubiquitin editing enzyme A20 (De Valck et al., 1999; Gachon et al., 1998; Jin et al., 1997; Ling and Goeddel, 2000) . TAX1BP1 inhibits TNF-induced NF-kB signals and appears to perform this function by collaborating with A20 to regulate ubiquitin-dependent signaling events (Iha et al., 2008; Shembade et al., 2007) . Recently described Tax1bp1 mutant mice exhibit embryonic lethality or cardiac valvulitis, depending on the targeting strategy (Iha et al., 2008; Nakano et al., 2013; Shembade et al., 2007) . As Tax is implicated in the transformation of human T cell lymphomas by HTLV, TAX1BP1's identification as a Tax binding partner suggests that TAX1BP1 may have additional unique functions in T cells. However, TAX1BP1 functions in T cells have not been examined in detail. Here we show that TAX1BP1 drives autophagy early during T cell activation, providing L-cysteine and other amino acids that activate mTOR complexes and mTOR-dependent biosynthetic and bioenergetic transitions.
RESULTS

TAX1BP1 Enables the Metabolic Transition Necessary for T Cell Proliferation
To understand TAX1BP1's physiological functions, we generated TAX1BP1-deficient mice by eliminating parts of exons 6 and 7 of Tax1bp1 (Figures S1A and S1B). Immunoblot analyses of T cells from these Tax1bp1 À/À mice revealed the absence of TAX1BP1 ( Figure S1C ). Mating Tax1bp1 À/À male mice with Tax1bp1 +/À female mice yielded expected ratios of Tax1bp1
and Tax1bp1 À/À progeny, indicating TAX1BP1 is not required for embryonic development. Tax1bp1 À/À mice developed splenomegaly and lymphadenopathy by 10 weeks of age, with modestly elevated numbers of myeloid and B cells ( Figure 1A and data not shown). The numbers of naive and memory phenotype T cells were relatively preserved (Figures 1B and 1C) . To test whether TAX1BP1 regulates T cell responses, we first examined T cell receptor (TCR)-induced signaling by immunoblot analysis after stimulation with agonistic anti-CD3 antibody. (F) Intracellular quantification of TNF-a (left) and IL-2 (right) production 7 hr and 19 hr, respectively, after anti-CD3 and anti-CD28 stimulation. Mean values ± SD. (G) Cell surface expression of activation markers, CD69 and CD25, 24 hr after anti-CD3 and anti-CD28 stimulation.
Unless otherwise noted, all data presented here and hereafter are representative of at least three independent experiments. Please see also Figure S1 . 
Tax1bp1
À/À OT-I T cells were adoptively co-transferred into the same congenically distinct hosts, after which mice were immunized with LPS plus ovalbumin.
Mice were sacrificed at the indicated days after immunization and the percentage of total splenic CD8 + T cells that were WT OT-I and Tax1bp1 À/À OT-I T cells were plotted (left). The relative percentage of total OT-I T cells that were either WT OT-I or Tax1bp1 À/À OT-I T cells is also plotted (right modestly restricts TCR signaling ( Figure 1D ). Tax1bp1 À/À CD4 + T cells exhibited normal Ca 2+ flux immediately after TCR activation ( Figure 1E ). These cells also produced normal amounts of TNF and IL-2 by intracellular cytokine staining ( Figure 1F ). Lastly, expression of the cell surface activation markers CD69 and CD25 were induced normally in Tax1bp1 À/À T cells 24 hr after stimulation ( Figure 1G ). Hence, initial TCR-induced activation events are preserved in Tax1bp1 À/À T cells.
To study antigen-specific T cell-autonomous roles of TAX1BP1 in vivo, we bred Tax1bp1 À/À mice with TCR transgenic and 7.5% of total transferred OT-I cells, respectively ( Figure 2A ). As these analyses were performed on congenically marked WT and Tax1bp1 À/À OT-I T cells within the same recipient mice, TAX1BP1 supports T cell expansion in a cell-autonomous fashion. Hence, Tax1bp1 À/À T cells exhibit defects in proliferation, survival, or both, compared to control T cells. To better understand why Tax1bp1 À/À T cells expand poorly,
we quantitated the numbers of congenically marked Tax1bp1
and control T cells in mixed cultures after in vitro TCR stimulation. 2 days after stimulation, the numbers of Tax1bp1
T cells increased less than control T cells in these mixed cultures, confirming that TAX1BP1 supports T cell expansion in a cellautonomous fashion ( Figure 2B ). To assess whether TAX1BP1 regulates proliferation, we labeled T cells with CFSE in a 1:1 mixed culture and assayed CFSE dilution after TCR stimulation. Fewer Tax1bp1 À/À T cells diluted CFSE than control cells, suggesting that TAX1BP1 supports T cell proliferation ( Figure 2C ). To address potential caveats associated with aberrant development, we generated mixed bone marrow chimeras by reconstituting sub-lethally irradiated C57BL/6 (CD45. Figure S2A ). Tax1bp1 mRNA expression decreased during T cell activation, suggesting that TAX1BP1 protein expression was at least partially regulated post-translationally ( Figure S2B ). As the proliferation defect of Tax1bp1 À/À T cells occurred despite normal initial TCR-induced NF-kB, MAP kinase, and Ca 2+ signaling, we tested whether this defect would persist when TCR complexes were bypassed.
À/À T cells failed to proliferate normally after stimulation with PMA and ionomycin, or with conconavalin A, reinforcing the notion that TAX1BP1 supports T cell proliferation at a step downstream of initial TCR signaling ( Figure 2C ). Upon TCR and CD28 co-receptor ligation, naive T cells exit G 0 to enter G 1 and S cell cycle phases, where they rapidly increase cellular mass before completing mitosis. To better understand why activated Tax1bp1 À/À T cells fail to proliferate as readily as control T cells, we hypothesized that these cells might fail to transition from resting cells to proliferating cells. We assessed the expression of cell cycle phase-specific cyclins after TCR activation. These studies revealed that cyclins D2 and D3 were induced normally in Tax1bp1 À/À T cells during the first 36 hr after T cell activation ( Figure 2E ). In addition, p27 was degraded normally ( Figure 2E ). These results indicate that TAX1BP1 is not required for the transition of T cells from G 0 to G 1 . By contrast, induction of the S phase-specific cyclins, cyclin A and cyclin E, were markedly deficient in stimulated Tax1bp1 À/À T cells compared to control T cells ( Figure 2E and data not shown). These findings suggest that Tax1bp1 À/À T cells transition normally from G 0 to G 1 but fail to efficiently progress through S phase. S phase is characterized by the synthesis of nucleic acids, proteins, and other cellular building blocks necessary for cellular division. To assess the ability of Tax1bp1 À/À T cells to synthesize new DNA during S phase, we measured the uptake and DNA content of these cells using bromodeoxyuridine (BrdU) labeling. BrdU incorporation was markedly delayed in Tax1bp1 À/À T cells when compared to control T cells, indicating that TAX1BP1 is required for de novo DNA synthesis ( Figure 2F ). These experiments also indicated that very few dying cells, represented by sub-2N amounts of DNA, were present at these early time points (24 hr after stimulation) in WT and Tax1bp1 À/À T cells.
Therefore, TAX1BP1 is not required for initial TCR signaling and T cell activation, but is required for DNA synthesis and T cell transition through S phase. In addition to replicating DNA, cells synthesize proteins, lipids, and a variety of other cellular components during S phase. Hence, the failure of Tax1bp1 À/À T cells to transition through S phase could be due to defects in biosynthetic functions. The (legend continued on next page) biosynthesis of cellular components causes the increase of cell size of recently activated T cells. We therefore measured the size of activated T cells by flow cytometry. These experiments revealed greater than 68% increase in forward scatter area for WT CD4 + T cells but only a 33% increase for Tax1bp1 À/À CD4 + T cells at 18 hr after stimulation ( Figure 3A ). To assess biosynthetic activity in these cells, we measured the relative amounts of specific metabolites by semiquantitative mass spectrometry 24 hr after TCR stimulation. These experiments revealed that Tax1bp1 À/À T cells possessed lower amounts of nucleotides AMP and UMP ( Figure 3B ). These cells also possessed lower amounts of ribose-5-phosphate, a key component of the ribose phosphate shunt and nucleoside biosynthesis ( Figure 3C ). Thus, Tax1bp1 À/À T cells possess biosynthetic deficits that compromise their progression through S phase. In addition to synthesizing new cellular components, newly activated T cells undergo a burst of glycolytic activity to generate ATP. To determine whether TAX1BP1 is required for this bioenergetic transition, we measured glycolytic activity using Seahorse. These assays revealed that Tax1bp1 À/À T cells exhibited consistently lower extracellular acidification rates (ECAR) than control T cells after glucose, reflecting lower production of lactic acid and lower glycolytic activity ( Figure 3D ). Consistent with this finding, semiquantitative mass spectrometric measurement of intracellular lactate revealed reduced amounts of this metabolite ( Figure 3E ). Tax1bp1 À/À T cells also exhibited lower glycolytic capacity after treatment with the ATP synthase inhibitor oligomycin ( Figure 3D ). To further evaluate glycolysis in these cells, we measured key glycolytic intermediates by mass spectrometry. These studies revealed that glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-diphosphate, and pyruvate were reduced in Tax1bp1 À/À T cells ( Figure 3F ). Therefore, TAX1BP1
supports the ability of recently activated T cells to enhance glycolysis. Increased glycolytic activity is supported by increased cellular glucose uptake via the GLUT1 transporter, a protein that is transcriptionally induced and actively partitioned to the cell surface (Maciver et al., 2008) . We therefore measured the surface expression of GLUT1. Surface biotinylation and immunoblotting experiments revealed that surface GLUT1 expression was deficient in Tax1bp1 À/À T cells ( Figure 3G ). After internalization, glucose is phosphorylated by hexokinase 2, thereby trapping it within cells. Hexokinase 2 is normally induced in T cells after TCR stimulation. Hexokinase 2 expression was induced poorly in Tax1bp1 À/À T cells when compared with control T cells (Figure 3H) . Hence, TAX1BP1 supports the ability of T cells to acquire and metabolize glucose. Biosynthetic and bioenergetic defects in Tax1bp1 À/À T cells could be caused by problems with mitochondrial homeostasis.
We therefore measured mitochondrial volume in resting and activated T cells using MitoTracker dye labeling. These assays revealed normal mitochondrial mass in resting and activated Tax1bp1 À/À T cells ( Figure 4A ). Mitochondrial dysfunction can lead to increased mitochondrial production of reactive oxygen species (ROS). We therefore measured mitochondrial ROS production by labeling T cells with MitoSOX. These experiments showed similar amounts of mitochondrial ROS in Tax1bp1
and control T cells before and after TCR activation ( Figure 4B ). Therefore, TAX1BP1 deficiency compromises the metabolic transition of T cells without grossly perturbing mitochondria.
TAX1BP1 Promotes mTORC1 Complex Formation and mTORC1 Activity
The studies above suggest that TAX1BP1 supports the biosynthesis of cellular building blocks, the import of glucose, and the bioenergetic transition to glycolysis during T cell activation. As the induction of these processes in lymphocytes is largely dependent upon mammalian TOR (mTOR) activation, we hypothesized that TAX1BP1 might support mTOR activation. We first tested the phosphorylation of AKT at serine 473, a phosphorylation target of the mTORC2 complex (Sarbassov et al., 2005) . pAKT S473 was induced similarly in Tax1bp1 À/À and control T cells ( Figure 4C ).
We next tested the phosphorylation of 4EBP1, a protein that is phosphorylated by mTORC1 (Gingras et al., 1999) . 4EBP1 phosphorylation relieves translational inhibition of mRNAs, mediating a major mechanism by which mTOR supports protein translation (Gingras et al., 2001 ). Phosphorylation of 4EBP1 at both serine 65 and threonine 37 was markedly reduced at 16 and 20 hr in activated Tax1bp1 À/À cells compared to control T cells ( Figure 4C ).
This result suggests that TAX1BP1 is important for activating mTORC1. Total 4EBP1 protein was also reduced in Tax1bp1
T cells, while 4EBP1 mRNA was comparable, suggesting that TAX1BP1-dependent activation of mTORC1 supports 4EBP1 protein translation ( Figures 4C and 4D) . Phosphorylation of S6, a substrate of the mTORC1 target S6 kinase, was relatively normal in Tax1bp1 À/À T cells ( Figure 4C ). These findings align with prior data showing that 4EBP1, rather than S6, is the ribosomal target most critical for translational regulation by mTOR (Hsieh et al., 2010; Salmond et al., 2015) . Finally, as mTORC1 activation depends on both amino acid sensing and phosphorylation of AKT threonine 308 (Inoki et al., 2002; Manning et al., 2002) , we measured pAKT T308 induction in Tax1bp1
and control T cells. These experiments revealed relatively normal amounts of pAKT T308 in Tax1bp1 À/À T cells ( Figure 4E ). Hence, TAX1BP1 supports mTORC1 activation and may perform this function independently of AKT activation. Reduced mTOR activity could be due to compromised formation of mTOR complexes. We therefore immunoprecipitated mTOR from stimulated T cells and immunoblotted for the presence of Raptor and Rictor, proteins that define mTORC1 and mTORC2 complexes, respectively. Tax1bp1 À/À T cells contained markedly reduced mTOR-Raptor (mTORC1) complexes, while mTOR-Rictor (mTORC2) complexes were relatively preserved ( Figure 4F ). c-MYC has been reported to support T cell metabolism (Wang et al., 2011) . However, c-MYC expression was normal in Tax1bp1 À/À T cells ( Figure S3 ), indicating that TAX1BP1 supports T cell metabolism independently of c-MYC. These findings reveal that TAX1BP1 supports the formation of mTORC1 complexes and mTORC1-dependent translation and phosphorylation of 4EBP1.
TAX1BP1 Supports Autophagy Induction in Activated T Cells mTOR activation requires engagement of amino acid sensors, and autophagolysosomes can supply intracellular amino acids that activate mTOR in model cell lines (Beugnet et al., 2003; Shigemitsu et al., 1999) . In addition, TAX1BP1 may overlap with optineurin and NDP52 in supporting autophagy, perhaps functioning as an adaptor for selected cargos (Tumbarello et al., 2012) . Accordingly, we hypothesized that TAX1BP1 might support autophagy-mediated nutrient recycling and priming of mTOR in activated T cells. We tested the ability of activated Tax1bp1 À/À T cells to perform autophagy by measuring lipidation of the autophagosomal protein LC3. These experiments revealed that Tax1bp1 À/À T cells exhibited marked defects in LC3 lipidation compared to control T cells ( Figure 5A ). These defects persisted in the presence of the H + ATPase inhibitor bafilomycin A1, which inhibits vacuolar acidification and prevents late steps of autophagy flux, thereby allowing direct assessment of LC3 lipidation rates ( Figures 5A and 5B) . Notably, LC3 lipidation defects were observed between 3 and 8 hr after T cell activation, time points that precede defects in mTORC1 formation (between 13 and 20 hr). Naive Tax1bp1 À/À T cells exhibited normal LC3 lipidation when cultured with Hank's balanced salt solution (HBSS), with or without baflomycin ( Figure 5C ). Moreover, Tax1bp1
MEFs exhibited normal starvation-induced autophagy (data not shown). Therefore, TAX1BP1 is not required for global autophagy in either naive T cells or MEFs. Hence, TAX1BP1 is specifically required for early autophagy induction during T cell activation.
L-Cysteine Restores mTORC1 Activity and Proliferation in T Cells Deficient for TAX1BP1 or Generalized Autophagy
To test the idea that autophagy in activated T cells provides essential amino acids to activate mTOR complexes, we examined whether supplementation with selected amino acids could rescue mTOR activation and proliferation of autophagy-deficient or Tax1bp1 À/À T cells. Titration of multiple amino acids was performed to determine each amino acid's potential benefit to support proliferation without causing toxicity. Although glutamine and leucine are known to support T cell survival and proliferation, supplemental L-glutamine or L-leucine (in addition to the components present in complete RPMI media) did not restore the proliferation defect of Tax1bp1 À/À T cells compared to wild-type
T cells at any concentration tested ( Figure 5D and data not shown). By contrast, L-cysteine (L-cys), an amino acid that exists at extremely low concentrations in mammalian cells (Okayasu et al., 1997) , induced a dose-dependent rescue of Tax1bp1
T cells ( Figures 5D and 5E ). Supplementation with 5 mM L-cysteine, but not D-cysteine, rescued proliferation of Figure 5D ). L-methionine, another sulfur-containing amino acid, did not rescue the proliferation of these cells ( Figure 5D ). Thus, metabolically bioavailable cysteine, rather than associated redox changes, rescues the proliferation defect in Tax1bp1 À/À T cells.
To determine how L-cysteine restores the proliferative capacity of Tax1bp1
À/À T cells, we studied the cellular and biochemical responses of these cells. While L-cysteine had minimal effects on control T cells, this amino acid restored the cell size expansion of activated Tax1bp1 À/À T cells ( Figure 5F ). Moreover, L-cysteine restored defects in 4EBP1 translation and phosphorylation seen in Tax1bp1 À/À T cells, reflecting normalized mTORC1 activity ( Figure 6A ). L-cysteine also normalized hexokinase 2 induction in these cells, reflecting mTORC1-dependent activation of glycolysis ( Figure 6A ). Further, L-cysteine selectively restored the induction of cyclin A and hence cell cycle progression in Tax1bp1 À/À T cells ( Figure 6A ). Notably, L-cysteine did not correct the defects in LC3 lipidation in Tax1bp1 À/À T cells, indicating that this supplemental amino acid restored mTORC1 activity, metabolic transition, and cell cycling without rescuing TAX1BP1-dependent autophagy ( Figure 6B ). Therefore, TAX1BP1 mediates autophagy-dependent production of key amino acids including L-cysteine, and supplemental L-cysteine bypasses this autophagy defect and triggers mTORC1 activity. To further examine the concept that autophagy-dependent production of L-cysteine is critical for mTORC1 activation in T cells, we stimulated wild-type CD4 + T cells in the presence or absence of the autophagy inhibitor 3-methyladenine (3-MA), a class III PI-3K inhibitor. Predictably, T cells cultured with 0.5 mM 3-MA proliferated poorly compared to untreated cells. Notably, this defect was reversed when L-cysteine was added in addition to 3-MA ( Figure 6C ). We next sought to determine Please see also Figure S4 . whether impairment of autophagy by 3-MA in WT T cells led to decreased mTOR signaling by assessing 4EBP1 phosphorylation. Indeed, CD4
+ T cells cultured with 3-MA exhibited decreased 4EBP1 phosphorylation, which was restored in T cells cultured with 3-MA and L-cys ( Figure 6D ). Treatment of WT T cells with another autophagy inhibitor, Vps34IN1, also suppressed early T cell proliferation, and this defect was partly rescued by L-cysteine ( Figures S4A and S4B ). To further test the ability of bioavailable L-cysteine to rescue autophagy-deficient T cells, we stimulated Atg5 flox/flox Cd4-cre + T cells in the presence or absence of L-cysteine and measured cell division. ATG5-deficient T cells proliferated poorly compared to wildtype cells as expected (Pua et al., 2007) , and L-cysteine normalized cell division of these cells ( Figure 6E ). Hence, autophagydependent L-cysteine supports mTORC1 activation during early T cell activation.
The LC3 Interacting Motif of TAX1BP1 Mediates Its
Binding to LC3 and GABARAP Family Proteins and Supports T Cell Proliferation TAX1BP1 binds to the autophagy molecule LC3 and to ubiquitin and has been postulated to function as an adaptor that bridges ubiquitinated cargos to LC3 proteins (Newman et al., 2012; Tumbarello et al., 2015) . We therefore investigated which of TAX1BP1's biochemical functions are required for supporting T cell proliferation. We devised an assay to test which forms of TAX1BP1 may rescue proliferation of activated Tax1bp1
T cells. Stimulation of naive T cells with anti-CD3 and anti-CD28 agonistic antibodies, followed by resting in 20 U/mL IL-2 for 6 days, led to the reduction of T cell size to that of naive T cells. Subsequent re-activation of Tax1bp1 À/À and control T cells with agonist anti-CD3 and anti-CD28 antibodies recapitulated the same defects in cell size expansion and cellular proliferation observed during the initial activation of naive T cells (data not shown). We utilized this approach to virally transduce TAX1BP1 constructs into Tax1bp1 À/À T cells during their initial activation, after which the function of these constructs could be assayed during the second stimulation. The N terminus of TAX1BP1 contains one atypical LC3-interacting region (LIR) sequence (LVV) and one putative LIR that is reminiscent of a canonical LIR sequence (WVGI) (Newman et al., 2012; Tumbarello et al., 2015) . The center region of TAX1BP1 encodes a series of coiled-coiled (CC1-3) domains, one of which, CC2, has been shown to be important for homodimerization (Ling and Goeddel, 2000) . The C terminus contains two zinc finger motifs that orchestrate binding to ubiquitin (Figure 7A ; Iha et al., 2008; Tumbarello et al., 2015) . To determine which of these regions were necessary to support TAX1BP1-dependent proliferation, we generated DLIR, DZF, and DCC-ZF deletion mutants of TAX1BP1, introduced these mutants as well as wild-type TAX1BP1 into GFP-expressing lentiviral constructs, transduced these constructs into activated Tax1bp1
+ T cells, rested the cells for 5 days, labeled the cells with the proliferation dye eFluor670, re-activated the cells, and measured cell proliferation ( Figure 7A) .
Initial experiments of this nature revealed that Tax1bp1
T cells infected with wild-type TAX1BP1 lentivirus restored the ability of these cells to initiate T cell proliferation after TCR stimulation ( Figures 7B and 7C ). By contrast, Tax1bp1 À/À T cells transduced with a control GFP-nanoluciferase construct responded similarly to non-transduced (GFP-negative) Tax1bp1 À/À cells ( Figures 7B and 7C) . Thus, TAX1BP1 expression in peripheral T cells (rather than a developmental problem in Tax1bp1 À/À mice) accounts for TAX1BP1's role in supporting proliferation of activated T cells. In contrast with wild-type TAX1BP1, DLIR and DCC-ZF mutant forms of TAX1BP1 were incapable of augmenting proliferation of Tax1bp1 À/À T cells ( Figures 7B and 7C) . Hence, TAX1BP1's abilities to bind LC3 and to dimerize are important for supporting T cells. By contrast, the DZF mutant form of TAX1BP1, lacking ubiquitin binding motifs, retained the ability to accelerate cell division comparably to WT TAX1BP1 ( Figures 7B and 7C ). As controls, expression of each form of TAX1BP1 was verified in 293T cells ( Figure 7D ). In addition, zinc finger-mediated ubiquitin binding was preserved in the DLIR mutant version of TAX1BP1, indicating that this mutant retains this critical function ( Figure 7E ). Hence, TAX1BP1 requires LC3 binding, but not ubiquitin binding, to support proliferation of activated T cells.
As the LIR motifs of TAX1BP1 are thought to interact with LC3 proteins, we tested the ability of these TAX1BP1 mutants to directly bind LC3B. DLIR and DCC-ZF forms of TAX1BP1 were unable to bind recombinant GST-LC3B in a glutathione pulldown assay, whereas TAX1BP1 DZF retained the ability to bind GST-LC3B ( Figure 7D ). These data reinforce the notion that the LIR and coiled-coil regions of TAX1BP1 are necessary for both binding to LC3B and for supporting TAX1BP1-dependent T cell proliferation. Given this central importance of LC3 binding in TAX1BP1 function, and because several LC3 family members exist in cells, we further investigated these TAX1BP1-LC3 interactions. We used GST-fusion proteins of various LC3 family members to perform pull-down assays from whole cell lysates of normal activated T cells. These assays revealed that TAX1BP1 preferentially binds to LC3C, Gabarap, and GabarapL1 in normal T cells ( Figure 7F ). By contrast, p62, another putative autophagy adaptor expressed in T cells, exhibited preferential binding to LC3A, LC3B, LC3C, and GabarapL2 ( Figure 7F ). Considered together with the importance of TAX1BP1's LIR motifs in supporting T cell proliferation, selective TAX1BP1 binding to these LC3 members provides a biochemical basis for TAX1BP1's unique role in supporting autophagy and mTOR metabolism in stimulated T cells.
DISCUSSION
Our studies have unveiled links between the ubiquitin binding protein TAX1BP1, selective autophagy, mTORC1 activation, and the metabolic transition of activated T cells. Recent studies have highlighted the importance of a burst of glycolysis and biosynthesis in supporting the transition of small, slowly proliferating, naive T cells into activated T cells. We have found that naive Tax1bp1 À/À T cells initially respond normally to TCR stimulation, activating multiple signaling cascades, expressing G 1 phaseassociated cyclins, upregulating activation markers, and elaborating cytokines, but fail to coordinate the glycolytic and biosynthetic steps to support the completion of S phase and progression to G 2 and mitosis. These defects were evident in semiquantitative mass spectrometry assays, were manifest as small cells that failed to grow in size, and were accompanied by Seahorse bioenergetic defects. Thus, TAX1BP1 constitutes a critical link between initial T cell activation signals and the metabolic transformations that resting T cells undergo to begin proliferating. We have uncovered profound defects in mTORC1 activation in Tax1bp1 À/À T cells, including defective association of mTOR with Raptor and reduced 4EBP1 phosphorylation. Activation of mTORC1 requires AKT-dependent activation of mTOR via heterotrimeric tuberous sclerosis complex (TSC) and the monomeric GTPase, Ras homolog enriched in brain (Rheb) (Powell et al., 2012) . In addition, recent studies in model cell lines suggest that mTORC1 activation requires amino acid sensors that detect the presence of adequate amounts of these metabolites Wolfson et al., 2016) . As we found that Tax1bp1 À/À T cells exhibit defects in mTORC1 complex formation and 4EBP1 phosphorylation, but preserved pAKT T308 , TAX1BP1's role in activating mTORC1 appears to be mediated by amino acid sensing rather than via AKT activation. We observed that defective autophagy precedes defective mTORC activation in Tax1bp1 À/À T cells. Inhibiting autophagy suppressed mTOR activation in wild-type T cells, suggesting that autophagy-mediated recycling of intracellular organelles and/or proteins into autophagolysosomes provide amino acids to mTORC. Autophagolysosomes in T cells have been described to shift their contents from organelles to proteins during T cell activation (Hubbard et al., 2010) . Our discovery that L-cysteine restores mTORC activation but not autophagy defects in Tax1bp1 À/À T cells reinforces the concept that autophagyderived amino acids activate mTORC in T cells. It also raises the possibility that a specific cysteine sensor may couple this amino acid to mTORC1 activation. Hence, autophagy-dependent recycling of proteins and lysosomal access to bioavailable amino acids lead to mTORC1 activation in newly activated T cells. L-cysteine rescued metabolic and proliferative defects in ATG5-deficient T cells and 3-MA-treated (autophagy-deficient) T cells, indicating that L-cysteine replaces autophagy-dependent amino acids that activate mTOR and facilitate T cell proliferation. L-cysteine exists at extremely low concentrations in mammalian cells (Okayasu et al., 1997) . Treatment of mammalian cells with the proteasome inhibitor MG-132 selectively depletes intracellular cysteine, asparagine, and aspartate and causes cell death. This death can be prevented with L-cysteine supplementation (Suraweera et al., 2012) . Among all amino acids, L-cysteine is present at the lowest concentration in the blood plasma (Chawla et al., 1984; Eck et al., 1989; Saetre and Rabenstein, 1978) . Meanwhile, activated T cells have strong transport activity for cysteine via the alanine, serine, and cysteine-type amino acid transporter (ASC) but only a weak membrane transport activity for cystine (x c À system). The oxidation of cystine to cysteine by antigen-presenting cells (APCs), followed by APC secretion of cysteine to T cells, may be an important mechanism by which APCs support T cell activation in vivo (Angelini et al., 2002; Gm€ under et al., 1991 Gm€ under et al., , 1990 . This mechanism could help explain why Tax1bp1 À/À T cells exhibit milder metabolic deficits in vivo than in vitro (data not shown). Hence, L-cysteine joins L-glutamine and L-leucine as critical amino acids supporting T cell responses. Although TAX1BP1 has recently been reported to support xenophagy and mitophagy, our studies in MEFs indicate that TAX1BP1 is not a global autophagy mediator akin to ATG5 (Lazarou et al., 2015; Tumbarello et al., 2015) . Combined loss of TAX1BP1 with optineurin and NDP52 autophagy receptors led to global autophagy defects (Tumbarello et al., 2012) , suggesting that these proteins may share partially redundant functions. By contrast, other autophagy receptors such as p62 and optineurin are expressed in T cells, so the failure to compensate for TAX1BP1 appears to reflect functional specification rather than differential expression. Indeed, while p62 decreases in model cell lines undergoing autophagy, p62 increases in T cells during T cell activation ( Figure S3 ; Martin et al., 2006) . Together, these studies suggest that specialized forms of autophagy may regulate activating T cells distinctly from other cell types. A20, a binding partner for TAX1BP1, has also been linked to autophagy. Like TAX1BP1-deficient T cells, A20-deficient T cells exhibit reduced autophagy (Matsuzawa et al., 2015) . Hence, A20 and TAX1BP1 might collaborate to support autophagy. However, A20 expression is normal in TAX1BP1-deficient T cells, suggesting that TAX1BP1 performs this function independently of A20 ( Figure S3 ). In addition, in marked contrast with TAX1BP1-deficient T cells, A20-deficient T cells display increased mTOR activity, and this increased mTOR activity may suppress autophagy in A20-deficient cells (Matsuzawa et al., 2015) . Therefore, A20 and TAX1BP1 probably regulate mTOR activity via distinct mechanisms. The epistatic relationships between these proteins remains to be explored.
TAX1BP1 has been described as a selective autophagy receptor, a protein that bridges selected ubiquitinated cargos to autophagosome components (Birgisdottir et al., 2013; Rogov et al., 2014) . However, our discovery that TAX1BP1 requires its LIR motif but not its ubiquitin binding motifs to support T cell proliferation suggests that TAX1BP1 performs this critical function in an LC3-dependent manner but independently of ubiquitinated proteins. Hence, TAX1BP1 may support autophagosome progression beyond acting as a cargo adaptor. Our findings that TAX1BP1 and p62 exhibit differential preferences in binding to LC3 family proteins could begin to explain why TAX1BP1 but not p62 supports autophagy in activated T cells (Martin et al., 2006) . Finally, the HTLV-1 Tax1 protein has recently been reported to promote autophagy, suggesting that Tax1 may divert TAX1BP1 to selected autophagosomes in HTLV-1-infected T cells (Ren et al., 2015) . The HTLV-2 Tax2 protein can also activate autophagy and immortalize human CD4 + T cells (Ren et al., 2012) . Therefore, TAX1BP1 represents a class of autophagy-inducing protein that selectively supports T cell activation. Future studies should reveal how TAX1BP1 and related proteins regulate specialized forms of autophagy. In summary, we have discovered an unexpected function for TAX1BP1 in supporting autophagic flux, mTOR activation, and proliferation of recently activated T cells. This autophagic function triggers mTOR activation via the production of essential amino acids and requires TAX1BP1's LIR motifs. Hence, TAX1BP1 is a critical link between the initial TCR activation events and nutrient recycling that drives metabolic transition of activated T cells. Given the utility of the mTOR inhibitor rapamycin in suppressing immune responses in transplant patients (Calne et al., 1989; Morris, 1992) , our discoveries suggest that targeting TAX1BP1 may be an important approach to modulating T cell responses.
EXPERIMENTAL PROCEDURES Mice and In Vivo Experiments
Recombineering was used to generate a gene-targeting construct from a C57BL/6J bacterial artificial chromosome containing Tax1bp1 ( Figure S1A ), and successfully targeted C57BL/6 ES cells (PRX-B6T, Primogenix) were injected into blastocysts. All animal experiments were performed in compliance with UCSF IACUC-approved protocols.
Cell Purification, Culture, Stimulation, and Analyses After red blood cell lysis, murine LN and spleen T cells were enriched to >90% purity using Dynabeads Untouched Mouse CD4 Cells Kit (Invitrogen). For some experiments, naive cells (CD44 lo CD62L hi ) were sorted using a MoFlo high-speed sorter (Beckman Coulter). Cells were analyzed on a LSR II flow cytometer (BD) and analyzed with FlowJo software (Tree Star).
For TCR proximal signaling experiments, purified T cells were stimulated with anti-CD3 mAb followed by crosslinking with goat anti-hamster IgG for the indicated times at 37 C with gentle shaking. For stimulations >1 hr, purified T cells were stimulated with plate-coated anti-CD3 and anti-CD28, PMA plus ionomycin, or concanavalin A as indicated. Calcium flux was measured using Fluo-4 NW (Invitrogen) according to the manufacturer's instructions with modifications. In brief, 4 3 10 6 purified CD4 T cells were loaded with Fluo-4 NW dye mix for 30 min at 37 C followed by 30 min at 25 C. After labeling, cells were recorded for background fluorescence by flow cytometry before addition of anti-CD3 at 30 s and goat anti-hamster IgG at 120 s. Detailed protocols are described in Supplemental Experimental Procedures.
Mitochondria and Mitochondrial ROS Quantitation
Mitochondria quantitation was performed using MitoTracker Green FM by flow cytometry using the manufacturer's instructions (Invitrogen). Mitochondrial ROS quantitation was performed using MitoSOX Red by flow cytometry using the manufacturer's instructions (Invitrogen).
Seahorse Assays
Purified CD4 T cells were stimulated with plate-bound anti-CD3 and anti-CD28 for 24 hr. After stimulation, cells were analyzed using the XF Glycolysis Stress Test according to manufacturer's instructions (Seahorse Bioscience). An XF-24 Extracellular Flux Analyzer (Seahorse Bioscience) was used to measure ECAR in response to 10 mM glucose, 1 mM oligomycin, and 100 mM 2-deoxyglucose.
Molecular Analyses
Cells were incubated in lysis buffer (10 mM HEPES [pH 7.4], 150 mM NaCl, 0.5% NP-40, or 0.3% CHAPS) supplemented with complete EDTA-Free Protease Inhibitor Cocktail (Roche), phosphatase inhibitors (1 mM Na 3 VO 4 and 10 mM NaF), and 10 mM N-ethylmaleimide and centrifuged for 10 min (21,000 3 g at 4 C). Supernatants were used for immunoprecipitation assays, pull-down assays, and immunoblotting. Semiquantitative mass spectrometry studies were performed using five replicates as previously described (Louie et al., 2016) . Quantitative real-time PCR was performed using Taqman primers on an ABI 7300 (Applied Biosystems). Detailed protocols are described in Supplemental Experimental Procedures.
Lentivirus Preparation and T Cell Transduction
Tax1bp1 À/À T cells were infected with lentiviruses encoding WT and mutant TAX1BP1 constructs 24 hr after activation. Culture medium was replaced with complete RPMI containing 20 U/mL rhIL-2 (Peprotech) at 1 day and 3 days after spinfection. 5 days after spinfection, cells were labeled with eFluor670 (eBioscience) and re-stimulated using anti-CD3 and anti-CD28 antibodies. Detailed protocols are described in Supplemental Experimental Procedures. 
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